Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 10, 2020

Bahat v. Mei Pharma, Inc. et al

Track this case

Case Number:

3:20-cv-01543

Court:

California Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

William Q. Hayes

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 10, 2020

    MEI Pharma Lied About Cancer Drug's Potential, Investor Says

    MEI Pharma Inc. and its executives lied to investors about setbacks in the development of a cancer drug, violating federal securities laws and leading to artificially inflated stock prices, a shareholder alleged in a proposed class action brought Monday in California federal court.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login